ARS-1 with URTI
EPI 014
Phase 1 small_molecule completed
Quick answer
ARS-1 with URTI for Upper Respiratory Tract Infection is a Phase 1 program (small_molecule) at ARS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARS Pharmaceuticals
- Indication
- Upper Respiratory Tract Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed